{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-001717","form_type":"8-K","ticker":"ENVB","cik":"0000890821","company_name":"Enveric Biosciences, Inc.","filed_at":"2024-01-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.190577+00:00","generated_at":"2026-06-07T02:48:00.378230+00:00","sec_items":["2.05"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Enveric Biosciences cuts 50% of workforce (7 positions) to reduce costs","bullets":["Approximately 7 positions eliminated, representing ~50% of global workforce, to streamline operations.","Estimated severance and transition costs of ~$40,000, to be recognized in Q1 2024.","RIF expected to be substantially complete by February 15, 2024.","Company cites cost reduction and organizational streamlining as reasons for the action."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-001717","json":"https://secwatch.observer/filing/0001493152-24-001717.json","markdown":"https://secwatch.observer/filing/0001493152-24-001717.md","text":"https://secwatch.observer/filing/0001493152-24-001717.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/890821/000149315224001717/0001493152-24-001717-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/890821/000149315224001717/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T02:48:00.378230+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"b5f1f545348bdad7a84a0417dc13f760a026767d","claim":"Enveric Biosciences, Inc. announced a restructuring with charges of approximately $40,000 (approximately seven positions, representing approximately 50% of the Company's global workforce).","evidence_excerpt":"to decrease its costs and create a more streamlined organization to support its business. In connection with the RIF, the Company currently estimates it will incur approximately $40,000 of costs, consisting primarily of cash severance costs and transition support services for impacted employees, which the Company expects to recognize in the first quarter of 2024.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/890821/000149315224001717/0001493152-24-001717-index.htm","confidence":0.99,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $40,000"},{"label":"Headcount","value":"approximately seven positions, representing approximately 50% of the Company's global workforce"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}